ATE78685T1 - Propiophenonderivate zur behandlung der pollakiurie (drang zu haeufiger harnentleerung). - Google Patents

Propiophenonderivate zur behandlung der pollakiurie (drang zu haeufiger harnentleerung).

Info

Publication number
ATE78685T1
ATE78685T1 AT87119084T AT87119084T ATE78685T1 AT E78685 T1 ATE78685 T1 AT E78685T1 AT 87119084 T AT87119084 T AT 87119084T AT 87119084 T AT87119084 T AT 87119084T AT E78685 T1 ATE78685 T1 AT E78685T1
Authority
AT
Austria
Prior art keywords
treatment
pollakiuria
uring
urgency
straight
Prior art date
Application number
AT87119084T
Other languages
English (en)
Inventor
Yasuo Itoh
Hideo Kato
Eiichi Koshinaka
Kouji Morikawa
Toshie Yamauchi
Original Assignee
Hokuriku Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17984801&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE78685(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hokuriku Pharmaceutical filed Critical Hokuriku Pharmaceutical
Application granted granted Critical
Publication of ATE78685T1 publication Critical patent/ATE78685T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT87119084T 1986-12-26 1987-12-23 Propiophenonderivate zur behandlung der pollakiurie (drang zu haeufiger harnentleerung). ATE78685T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61308747A JPH0637389B2 (ja) 1986-12-26 1986-12-26 頻尿治療剤
EP87119084A EP0273375B2 (de) 1986-12-26 1987-12-23 Propiophenonderivate zur Behandlung der Pollakiurie (Drang zu häufiger Harnentleerung)

Publications (1)

Publication Number Publication Date
ATE78685T1 true ATE78685T1 (de) 1992-08-15

Family

ID=17984801

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87119084T ATE78685T1 (de) 1986-12-26 1987-12-23 Propiophenonderivate zur behandlung der pollakiurie (drang zu haeufiger harnentleerung).

Country Status (10)

Country Link
US (1) US4912116A (de)
EP (1) EP0273375B2 (de)
JP (1) JPH0637389B2 (de)
KR (1) KR920006907B1 (de)
AT (1) ATE78685T1 (de)
CA (1) CA1295251C (de)
DE (1) DE3780787T2 (de)
DK (1) DK685787A (de)
HU (1) HU202752B (de)
ZA (1) ZA879663B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1233715B (it) * 1989-07-14 1992-04-14 Menarini Farma Ind Uso in terapia della 10-ammino-5,6diidro-11h= dibenzo (b,e) azepina-6,11-dione e derivati, quali farmaci utili per il trattamento dell'incontinenza urinaria
DK0414391T3 (da) * 1989-08-04 1995-04-03 Mitsui Toatsu Chemicals Aminoketonderivater og deres anvendelse
US5338857A (en) * 1989-08-04 1994-08-16 Mitsui Toatsu Chemicals Incorporated Aminoketone derivatives of 1,2-oxazole and use thereof
AT409083B (de) * 1999-04-01 2002-05-27 Sanochemia Pharmazeutika Ag Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
DE10341923A1 (de) * 2003-09-11 2005-04-07 Heinl, Alexander, Dr.med. Verwendung von Tolperison
AT500144A1 (de) * 2004-03-05 2005-11-15 Sanochemia Pharmazeutika Ag Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung
WO2006112565A1 (en) * 2005-04-21 2006-10-26 Dreampharma Corp. Therapeutic drugs for pollakiuria and urinary incontinence containing optical active propiophenon and its salts
CA2648782A1 (en) * 2006-04-20 2008-01-10 Sanochemia Pharmazeutika Ag Method for administering tolperisone
US8604031B2 (en) * 2006-05-18 2013-12-10 Mannkind Corporation Intracellular kinase inhibitors
EP2155643B1 (de) * 2007-06-08 2016-08-10 MannKind Corporation Ire-1a-inhibitoren
WO2009038771A2 (en) * 2007-09-19 2009-03-26 Massachusetts Institute Of Technology Tolperisone and tolperisone-like drugs for the treatment of k-ras associated cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139627A (en) * 1977-10-06 1979-02-13 Beecham Inc. Anesthetic lozenges
JPS5933276A (ja) * 1982-08-20 1984-02-23 Hokuriku Seiyaku Co Ltd ３−ピロリジノ置換プロピオフエノン誘導体
HU33131A (de) * 1984-01-26 1984-10-29

Also Published As

Publication number Publication date
EP0273375B2 (de) 1995-05-10
JPH0637389B2 (ja) 1994-05-18
HU202752B (en) 1991-04-29
US4912116A (en) 1990-03-27
KR880007462A (ko) 1988-08-27
DK685787D0 (da) 1987-12-23
JPS63162621A (ja) 1988-07-06
DE3780787D1 (de) 1992-09-03
ZA879663B (en) 1988-06-23
DE3780787T2 (de) 1995-08-24
CA1295251C (en) 1992-02-04
EP0273375A2 (de) 1988-07-06
EP0273375A3 (en) 1990-05-16
HUT45400A (en) 1988-07-28
KR920006907B1 (ko) 1992-08-22
EP0273375B1 (de) 1992-07-29
DK685787A (da) 1988-06-27

Similar Documents

Publication Publication Date Title
DE3774727D1 (de) Als antiemetika oder antipsychotika nuetzliche carboxamide.
ATE60761T1 (de) Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
PT87163A (pt) Process for preparing 1-phenyl-3-naphthalenyloxipropanamines
DE3850306D1 (de) Camptothecin-Derivate und Verfahren zu ihrer Herstellung.
ATE78685T1 (de) Propiophenonderivate zur behandlung der pollakiurie (drang zu haeufiger harnentleerung).
DE69120581D1 (de) 1,8-Naphthyridin-2-on-Derivate
DE3888340T2 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
IE45511L (en) Perhydro-aza-heterocycles.
IE40068B1 (en) Isoquinoline derivatives and process for preparing them and phamaceutical preparations comprising them
DE3586649D1 (de) Verwendung von spergualinderivaten zur herstellung von arzneimitteln mit immunodepressiver wirkung.
ES2058203T3 (es) Derivados del acido pirocatequincarboxilico, su obtencion y empleo como substancias activas para medicamentos.
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
ATE102955T1 (de) Zyklisches tetrapeptid und verfahren zu dessen herstellung.
NO180487C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksadiazolylfenoksyalkylisoksazoler
ATE47389T1 (de) Kondensierte siebengliedrige heterozyklische verbindungen, ihre herstellung und verwendung.
ES2062086T3 (es) Nuevos derivados de leucotrieno-b4, procedimientos para su preparacion y su utilizacion como medicamentos.
ATE60333T1 (de) D-nor-7-ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zubereitung und verwendung.
ATE66231T1 (de) Dioxolobenzisoxazolderivate und verfahren zu ihrer herstellung.
JPS5655369A (en) Pyridinemethanol derivative
DE3884878T2 (de) Uricosuretische Zusammensetzung.
ES8707254A1 (es) Un procedimiento para preparar un derivado de imidazopiridazina
JPS5212182A (en) Process for preparation of novel n- substituted indanespiropiperazine derivatives
TH1764A (th) อิมิดาโซเบนโซไดอะซิบีน